1      0

29.4 - Patients with advanced cirrhosis should receive blood products to correct coagulation abnormalities before invasive procedures

‐ May 1, 2021 2:30pm

Presentation Style: Debate

Learning Objectives:

  • Understand the balance between pro-hemorrhagic and pro-thrombotic tendencies in patients with cirrhosis at different stages
  • Understand the limitations of standard coagulation tests (INR, platelet count, fibrinogen) in predicting risk of post-procedural bleeding in patients with cirrhosis
  • Gain knowledge on the risk and potential benefits of blood product transfusion prior to invasive procedures in patients with cirrhosis


You must be logged in and own this session in order to post comments.